Mr. Les Kjosness reports

COMPANY TO COMMENCE TRADING TODAY ON FRANKFURT STOCK EXCHANGE

Marapharm Ventures Inc. is continuing to move forward in several areas and will begin trading on the Frankfurt Stock Exchange under the symbol FSE:2MO on Thursday, May 28, 2015.

Marapharm intends to create a global entity by pursuing commercial ventures in the medical marijuana business. It was established to enter the emerging market created by Canada's new Marijuana for Medical Purposes Regulations (MMPR). The company's original project is the construction of brand new facilities on 11 acres in British Columbia's Okanagan Valley with expansion plans in place to meet strategic advantages for growth and market penetration. Marapharm is currently in the process of its application for an MMPR licence.

In May, 2015, the company announced the purchase of 5.9 acres in the Apex Industrial Park, located in north Las Vegas, Nevada. The company has a provisional grow licence in place and will build a 70,000-square-foot medical marijuana facility. Building plans are completed and are in the final rounds for permitting. Construction will start within 60 days. In addition to the Las Vegas acquisition, Marapharm has entered into a letter of intent with the same business corporation for 90-day exclusive negotiation rights, and the right of first refusal for two additional Nevada medical marijuana licences, one medical and recreational marijuana grow operation in Colorado, one grow operation and a medical dispensary licence in Washington and one medical dispensary licence in California.

The Canadian market potential for medical marijuana is currently estimated at $1.2-billion, and the world market potential is estimated at $115-billion. As a result, Marapharm is well positioned to enjoy significant and consistent revenue growth for many years.

We seek Safe Harbor.